- Trials with a EudraCT protocol (25)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
25 result(s) found for: Acute Cholecystitis.
Displaying page 1 of 2.
EudraCT Number: 2009-013470-41 | Sponsor Protocol Number: PHRC N09 - Pr. REGIMBEAU | Start Date*: 2009-08-19 | |||||||||||
Sponsor Name:CHU d'Amiens | |||||||||||||
Full Title: Place de l’antibiothérapie postopératoire dans la cholécystite aiguë lithiasique. Antibiothérapie postopératoire de courte durée versus absence d’antibiothérapie postopératoire | |||||||||||||
Medical condition: cholécystite aiguë | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002629-95 | Sponsor Protocol Number: 170188 | Start Date*: 2022-08-02 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Department of vascular surgery, Lillebaelt Hospital | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Cefuroxime and Piperacillin Concentrations in the Biliary System | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Infection in the biliary system such as cholecystitis and cholangitis both as acute infections and post-operative infections. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002056-14 | Sponsor Protocol Number: AC-DC-01 | Start Date*: 2006-08-28 | |||||||||||
Sponsor Name:Universitätsklinikum Heidelberg | |||||||||||||
Full Title: Akute Cholezystitis – Frühe laparoskopische Operation versus antibiotischer Therapie mit elektiver Cholezystektomie im Intervall (ACDC-Studie) (Acute cholecystitis – early laparoscopic surgery vers... | |||||||||||||
Medical condition: Akute Cholezystitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004878-29 | Sponsor Protocol Number: NA | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:St. Antonius Hospital | |||||||||||||
Full Title: Perioperative antibiotic use in the treatment of acute calculous cholecystitis | |||||||||||||
Medical condition: Acute calculous cholecystitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010265-23 | Sponsor Protocol Number: EudraCTnr 2009-010265-23 | Start Date*: 2010-10-03 |
Sponsor Name:Gastrocentrum kirurgi | ||
Full Title: A prospective, randomized, blinded, placebo-controlled study of the value of preoperative treatment with Tazocin on bacterial contamination and infectious complications in patients with acute chole... | ||
Medical condition: Patients with cholecystitis scheduled for acute cholecystectomy. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005865-37 | Sponsor Protocol Number: PIL-629-WEB-0128-I | Start Date*: Information not available in EudraCT |
Sponsor Name:Medizinische Fakultät der Technischen Universität München, Vertreten durch den Dekan | ||
Full Title: Levofloxacin vs Piperacillin/Sulbactam and Sultamicillin in patients with acute cholecystitis. A double blind, randomized study. | ||
Medical condition: acute cholecystitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-005919-24 | Sponsor Protocol Number: C/399/2002 | Start Date*: 2006-07-19 |
Sponsor Name:Dr. Falk Pharma Portugal | ||
Full Title: Randomized, multicenter, double blind, placebo controlled trial, for the evaluation of the efficacy and tolerability of ursodeoxycholic acid on the dissolution of cholesterol gallstones (<15mm) aft... | ||
Medical condition: Randomized multicenter double blind, placebo controlled trial, for the evaluation of the efficacy and tolerability of UDCA on the dissolution of cholesterol gallstones (<15mm) after 18 months of th... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-003174-89 | Sponsor Protocol Number: AUDC/11 | Start Date*: 2013-01-28 | |||||||||||
Sponsor Name:Enrique De Madaria Pascual | |||||||||||||
Full Title: Ursodeoxycholic acid in the secondary prophylaxis of acute biliary pancreatitis: pilot clinical trial randomized double-blind. | |||||||||||||
Medical condition: Gallstone Dissolution | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002638-35 | Sponsor Protocol Number: 3.00 | Start Date*: 2012-07-31 |
Sponsor Name:Stockholms Läns Landsting, Karolinska Universitetssjukhuset Huddinge, Anestesikliniken | ||
Full Title: ALBUMIN KINETICS BY 123I-HSA A validation study on healthy volunteers, patients with acute inflammation, and patiens scheduled for major abdominal surgery | ||
Medical condition: A) healthy volunteers (transcapillary escape rate of albumin, plasmavolume, and turnover of albumin) B) Acute inflammation such as pancreatitis or cholecystitis C) Scheduled major abdominal surge... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000904-36 | Sponsor Protocol Number: IBS-DOTIG-ECM-2202 | Start Date*: 2022-05-09 | |||||||||||
Sponsor Name:Instituto de Investigación Biomédica de Salamanca | |||||||||||||
Full Title: Randomized clinical trial to evaluate the dose and administration time of indocyanine green in near-infrared fluorescent cholangiography during laparoscopic cholecystectomy. | |||||||||||||
Medical condition: Laparoscopic cholecystectomy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003245-29 | Sponsor Protocol Number: SA652013 | Start Date*: 2016-12-19 |
Sponsor Name:Amsterdam AMC, locatie AMC | ||
Full Title: Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after Roux-en-Y gastric bypass and Sleeve Gastrectomy | ||
Medical condition: Prevention of symptomatic gallstone disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-002121-80 | Sponsor Protocol Number: 47/2007/O/Sper | Start Date*: 2007-09-25 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: A prospective, double-blind, multi center, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin- Sulbactam 3 days in the treatment of localized communi... | |||||||||||||
Medical condition: localized community acquired intra-abdominal infection (IAI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001913-34 | Sponsor Protocol Number: TP-434-008 | Start Date*: 2013-08-16 | |||||||||||
Sponsor Name:Tetraphase Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared with Ertapenem in Complicated Intra-abdominal Infections | |||||||||||||
Medical condition: Complicated Intra-abdominal Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) CZ (Completed) EE (Completed) LT (Completed) DE (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002208-21 | Sponsor Protocol Number: TP-434-025 | Start Date*: 2016-09-27 | |||||||||||
Sponsor Name:Tetraphase Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared with Meropenem in Complicated Intra-abdominal Infections | |||||||||||||
Medical condition: Complicated Intra-abdominal Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) LV (Completed) EE (Completed) LT (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002119-27 | Sponsor Protocol Number: CXA-cIAI-10-08 | Start Date*: 2012-01-25 |
Sponsor Name:Cubist Pharmaceuticals, Inc. | ||
Full Title: A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PHASE 3 STUDY TO COMPARE THE EFFICACY AND SAFETY OF INTRAVENOUS CXA-201 WITH THAT OF MEROPENEM IN COMPLICATED INTRAABDOMINAL INFECTIONS | ||
Medical condition: Complicated Intraabdominal Infections | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) BE (Completed) LV (Completed) SK (Completed) LT (Completed) EE (Completed) RO (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-002120-41 | Sponsor Protocol Number: CXA-cIAI-10-09 | Start Date*: 2012-02-08 |
Sponsor Name:Cubist Pharmaceuticals, Inc. | ||
Full Title: A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PHASE 3 STUDY TO COMPARE THE EFFICACY AND SAFETY OF INTRAVENOUS CXA-201 WITH THAT OF MEROPENEM IN COMPLICATED INTRAABDOMINAL INFECTIONS | ||
Medical condition: Complicated Intra abdominal Infections | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) DE (Completed) PL (Completed) BG (Completed) LT (Completed) EE (Completed) LV (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-005604-54 | Sponsor Protocol Number: NXL104/2002 | Start Date*: 2009-04-10 | ||||||||||||||||
Sponsor Name:Novexel, S.A. | ||||||||||||||||||
Full Title: A prospective, multicentre, double-blind, randomized, comparative study to estimate the safety, tolerability and efficacy of NXL104/ceftazidime plus metronidazole vs. meropenem in the treatment of ... | ||||||||||||||||||
Medical condition: Complicated intra-abdominal infections (cIAI) in hospitalised adults | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BG (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001117-42 | Sponsor Protocol Number: DORI-NOS-2001 | Start Date*: 2007-10-18 | ||||||||||||||||
Sponsor Name:Janssen Cilag International NV | ||||||||||||||||||
Full Title: A Randomized, Open-Label, Multicenter Study to Assess the Safety and Tolerability of Doripenem Compared With Imipenem in the Treatment of Subjects With Complicated Intra-Abdominal Infections or Ven... | ||||||||||||||||||
Medical condition: ventilator-associated pneumonia complicated intra-abdominal infections | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-002735-28 | Sponsor Protocol Number: I8F-MC-GPGN | Start Date*: 2020-03-30 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: The Effect of Tirzepatide versus Dulaglutide on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes (SURPASS-CVOT) | |||||||||||||
Medical condition: Type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) HU (Ongoing) DE (Ongoing) SK (Trial now transitioned) BE (Trial now transitioned) GR (Trial now transitioned) NL (Trial now transitioned) PL (Trial now transitioned) ES (Ongoing) AT (Trial now transitioned) IT (Ongoing) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000485-35 | Sponsor Protocol Number: LRS114689 | Start Date*: 2011-07-27 | |||||||||||
Sponsor Name:GlaxoSmithKline Research and Development Ltd | |||||||||||||
Full Title: Study LRS114689: A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the treatment of complicated intra-abdominal infection in adults. | |||||||||||||
Medical condition: Intra-abdominal infections. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) HU (Prematurely Ended) ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.